Plain-English translation of ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are studying how to use multiple types of patient information—including tissue samples, genetic data, and blood tests—to better predict which ovarian cancer patients will respond well to standard chemotherapy and surgery. The goal is to develop personalized medicine tools that can identify patients at risk of treatment resistance early on, so doctors can make better treatment decisions for each individual patient.
Some ovarian cancer patients respond poorly to current standard treatments, but there's no reliable way to predict who will struggle ahead of time. This study aims to fill that gap by combining patient tissue, genetics, and blood information with artificial intelligence to create tools that help doctors choose the most effective treatment plan for each person.
You likely qualify if…
You likely don't qualify if…
Depending on your treatment plan, you will either receive chemotherapy before surgery or surgery first, followed by standard chemotherapy—all as part of your regular cancer care. Throughout your treatment and follow-up, researchers will collect tissue samples from surgeries and blood samples over time to study your genetics and track cancer markers. You will also have standard imaging scans to monitor your response to treatment. The study team will use this information to test new personalized medicine tools.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
Finland